在患有COPD的患者中,BLTR1降低了类固醇抵抗性益炎性CD28nullCD8+T淋巴细胞-溢出假说解释了吗?
Greg Hodge1,2, Hubertus Jersmann1,2, Mark Holmes1,2
1Chronic Inflammatory Lung Disease Laboratory, Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide 5001, Australia.
Biology
|September 28, 2023
概括
在COPD患者中,CD8+ T细胞上的Leukotriene B4受体1 (BLTR1) 的损失会增加炎症,并允许细胞迁移. 抑制BLTR1可能会减少全身炎症和并发病.
科学领域:
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
- 细胞生物学 细胞生物学
背景情况:
- 在吸烟者和COPD患者中,促炎性CD8+ T细胞和耐固醇的CD28nullCD8+衰老性淋巴细胞增加.
- 这些衰老的淋巴细胞从肺部迁移,可能导致COPD的全身炎症,尚未完全理解.
研究的目的:
- 为了研究白二烯B4受体1 (BLTR1) 在慢性阻塞性肺病 (COPD) 中衰老的CD8+T细胞迁移中的作用.
主要方法:
- 流细胞测量和西部斑被用来测量COPD患者和对照组的各种免疫细胞中的BLTR1,IFNγ和TNFα表达.
- 化疗测试是在白细胞子集上进行的,有和没有白丁B4 (LB4) 和普雷迪尼索隆刺激.
主要成果:
- 与对照人群相比,COPD患者在肺和血液中增加了BLTR1-CD28nullCD8+淋巴细胞.
- BLTR1-CD28nullCD8+ T和NKT样细胞比BLTR+细胞产生更多的IFNγ/TNFα,并且没有迁移到LTB4.
- 试验室前尼索隆治疗提高了BLTR1的表达,并促进了CD28nullCD8+细胞中的LB4介导迁移.
结论:
- 失去BLTR1与炎症潜力增加和COPD中抗类固醇CD8+T细胞的外周迁移有关.
- 旨在提高BLTR1的治疗策略可能会减轻COPD患者的全身炎症和相关并发症.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:20COPD: Pathogenesis and Clinical Features
327
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
327
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
01:26COPD: Management Using Bronchodilators and Corticosteroids
236
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
236
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K